Preimplantation genetic diagnosis allows women of childbearing age to select embryos that do not have genetic mutations.
When talking about genetic testing in patients with breast cancer, it is important to frame it as a personal choice that can benefit both the patient and their family, said Kristin Rojas, MD, breast surgical oncologist affiliated with the Brooklyn Breast Program at Maimonides Medical Center.
While more patients and providers are addressing the topic of genetic testing, preimplantation genetic diagnosis for those who are hoping to have children is not talked about as much. Through this process, clinicians can select embryos that do not have the BRCA1 or BRCA2 mutation to be used in reproduction.
Workflow, Educational Tools Improve Use of Silicone Film to Prevent Radiation Dermatitis
April 25th 2024Tools to educate oncology nurses and patients on the use of Mepitel film to prevent radiation dermatitis has improved the workflow around its introduction to patients with breast cancer, as well as its application and maintenance.
Olaparib Plus Chemo May Not Improve Outcomes vs Chemo Alone in BRCA Wild-Type TNBC
April 23rd 2024Patients with BRCA wild-type triple-negative breast cancer treated with olaparib on a gap schedule with chemotherapy did not experience improved responses compared with chemotherapy alone in the neoadjuvant setting.
Nurse Practitioners Weigh in on Data From the San Antonio Breast Cancer Symposium
January 16th 2023Loyda Braithwaite, MSN, RN, AGPCNP-BC, AOCNP; and Jamie Carroll, APRN, CNP, MSN, highlight presentations from the 2022 San Antonio Breast Cancer Symposium that will influence oncology nursing practice.